Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Ovid Therapeutics Inc..
Ovid Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Ovid Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Ovid Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Ovid Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Ovid Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Ovid Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Ovid Therapeutics Inc.- Key Facts
2.2 Ovid Therapeutics Inc.- Geographic Locations
2.3 Ovid Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Ovid Therapeutics Inc.- Business Divisions
2.5 Ovid Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Ovid Therapeutics Inc. Strategic Analysis Review
3.1 Ovid Therapeutics Inc.- Key Strategies
3.2 Ovid Therapeutics Inc.- Company Outlook Statement
3.3 Ovid Therapeutics Inc.- SWOT Analysis
3.3.1 Ovid Therapeutics Inc.- Key Strengths
3.3.2 Ovid Therapeutics Inc.- Key Weaknesses
3.3.3 Ovid Therapeutics Inc.- Potential Opportunities
3.3.4 Ovid Therapeutics Inc.- Potential Threats
3.4 Ovid Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Ovid Therapeutics Inc.- Business Overview
4.2 Ovid Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Ovid Therapeutics Inc.- Key Products
5.2 Ovid Therapeutics Inc.- Key Service Areas
5.3 Ovid Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Ovid Therapeutics Inc.- Company History
6.2 Ovid Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Ovid Therapeutics Inc.- Income Statements
7.2 Ovid Therapeutics Inc.- Balance Sheet
7.3 Ovid Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Ovid Therapeutics Inc.- Direct Competitors
8.2 Ovid Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Ovid Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Ovid Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
